Mckesson Corporation
Mckesson Corporation appears in FDA public data with 2 recalls, 0 510(k) clearances, 42 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0347-2024, Class II) was initiated on February 12, 2024.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 42
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0347-2024 | Class II | CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for | February 12, 2024 |
| D-1172-2018 | Class II | Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only | August 14, 2018 |